亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

  • Symic Bio Announces Closing of Investment led by CIP firstwordpharma
    April 26, 2019
    SAN FRANCISCO,?April 25, 2019?/PRNewswire/ --?Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced the closing of financings led by Cell Innovation Partners (CIP) ...
  • Symic Bio Enrolls First Patient in MODIFY2 Phase 2 Trial of SB-061 americanpharmaceuticalreview
    August 24, 2017
    Symic Bio announced the treatment of the first patient in the MODIFY2 Phase 2 clinical trial investigating SB-061?for pain management in mild-to-moderate osteoarthritis of the knee.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service